DNA Sequencing and PCR Markets

DNA Sequencing and PCR Markets

The focus of this TriMark Publications report is to describe the specific segment of the life sciences market called DNA sequencing. This analysis includes all of the generally-accepted DNA-oriented analytical activities that are currently used today, such as enabling technologies like polymerase chain reaction (PCR). It examines these measurement technology platforms and their reagents and supplies as utilized in biotechnology research, pharmacology and healthcare. Generally, diagnostic tests which are marketed primarily as over-the-counter products directly to patients are not included in this study, although there is inevitably some overlap. This examination will: 1) identify viable technology drivers through a comprehensive look at various platform technologies for molecular sequencing, including immunoassays electrophoretic methods, probe-based nucleic acid assays, microarrays and non-PCR sequencing; 2) obtain a complete understanding of the chief molecular sequencing tests for predictive, screening, prognostic, monitoring, pharmacogenomic and theranostic applications; 3) discover feasible market opportunities via an identification of high-growth applications in different therapeutic areas, with a focus on the biggest and expanding markets–communicable diseases, cardiology and oncology; and 4) focus on global industry development through an in-depth analysis of the major world markets for molecular sequencing, including forecasts for growth.

2.1.1 DNA Sequencing and PCR Applications Space

2.1.2 Proteomics

2.1.3 Products for the Genomics Market

3.1.1 Highlights of DNA Sequencing Market

3.1.2 Genomic Analysis Market Development

3.1.3 Leading U.S. and Canadian Companies Offering Sequencing Technology Platforms

3.1.4 Competition

3.1.5 Markets for DNA Sequencing

3.1.6 Market Opportunity

3.1.7 Market Dynamics

3.1.8 Overview of Current DNA Sequencing Technology Platforms and Players

3.1.9 Limitations of Current Sequencing Technologies

3.1.10 Overview of the Life Science Marketplace

3.1.11 Research Laboratories

3.1.11.1 Market Share

3.2.1 Systems Biology and the Need for More Effective Tools

3.2.2 Molecular Medicine and the New Therapeutics

3.2.3 Pharmacogenomics Using Genotyping and Phenotyping Clinical Biomarkers

3.2.4 The Market

3.3.1 Nucleic Acid Amplification Methods

3.3.2 Amplification of Refractory Mutation System (ARMS)

3.4.1 Product Description

3.4.1.1 Pricing

3.5.1 Nucleic Acid-Amplification and Detection Systems: How Big a Market?

3.5.2 Market Size 2004-2010 and Growth Projections in DNA Amplification Instrumentation

3.5.2.1 U.S. Market

3.5.2.2 European Market

3.5.3 Market Share of Key Players in DNA Amplification

3.6.1 Isolation of DNA for PCR Profiling

3.6.2 Analysis by PCR-Based DNA Typing

3.6.3 Rapid Isolation of DNA for RFLP and PCR

3.6.4 DNA for PCR-STR Typing

3.7.1 Products for the Genomics Market

3.7.2 Genetic Analysis Products

4.1.1 Primers for PCR

4.1.2 Equipment for PCR

5.1.1 Overview

5.3.1 Direct Signal Amplification Using the Invader Assay

5.3.2 Biosensor Technologies

5.3.2.1 DNA Hybridization Biosensor Chips

5.3.2.2 PNA-Based Biosensors

5.6.1 Use of DNA Sequencers

5.6.1.1 Capillary-Based Sequencers

5.6.1.2 Pyrosequencing

5.6.2 Use of Microarrays

5.10.1 The Technique

5.10.2 The Market

5.10.3 Gene Expression Monitoring Arrays

5.12.1 Locked Nucleic Acids (LNAs)

5.12.2 Multiplexed Nuclease-Protection Assay and ArrayPlate